Molecular Formula | C21H33ClN2O3 |
Molar Mass | 396.95132 |
Solubility | DMSO: ≥ 45 mg/mL |
Storage Condition | -20℃ |
In vitro study | Istaroxime hydrochloride acting as a positive inotropic compound through the inhibition of the Na + ,K + -ATPase. Istaroxime (PST2744) inhibits the Na + /K + -ATPase activity from dog kidney with an IC 50 value of 0.43 ± 0.15 μM. Inhibition of Na + /K + -ATPase activity in preparations from guinea pig kidney yielded potencies of 8.5 μM for PST2744. |
In vivo study | Istaroxime (PST2744) induces a progressive increase in +dP/dt max throughout the infusion that reaches 80% (ED 80 ) at the cumulative dose of 1.89±0.37 mg/kg and a peak of 140±3.5% at the dose (ED max ) of 4.88±0.6 mg/kg. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.519 ml | 12.596 ml | 25.192 ml |
5 mM | 0.504 ml | 2.519 ml | 5.038 ml |
10 mM | 0.252 ml | 1.26 ml | 2.519 ml |
5 mM | 0.05 ml | 0.252 ml | 0.504 ml |